Molecular hydrogen alleviates motor deficits and muscle degeneration in mdx mice

References

• Hoffman EP, Brown RH, Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919–28. doi: 10.1016/0092-8674(87)90579-4
   PubMed Web of Science ®Google Scholar
• Deconinck N, Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 2007;36:1–7. doi: 10.1016/j.pediatrneurol.2006.09.016
   PubMed Web of Science ®Google Scholar
• Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010;9:77–93. doi: 10.1016/S1474-4422(09)70271-6
   PubMed Web of Science ®Google Scholar
• Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010;9:177–89. doi: 10.1016/S1474-4422(09)70272-8
   PubMed Web of Science ®Google Scholar
• De Luca A. Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview. Acta Myol 2012;31:40–7.
   PubMedGoogle Scholar
• Abdel-Hamid H, Clemens PR. Pharmacological therapies for muscular dystrophies. Curr Opin Neurol 2012;25:604–8. doi: 10.1097/WCO.0b013e328357f44c
   PubMed Web of Science ®Google Scholar
• Angelini C, Peterle E. Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy. Acta Myol 2012;31:9–15.
   PubMedGoogle Scholar
• Partridge T. Animal models of muscular dystrophy – what can they teach us? Neuropathol Appl Neurobiol 1991;17:353–63. doi: 10.1111/j.1365-2990.1991.tb00735.x
   PubMed Web of Science ®Google Scholar
• Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 1984;81:1189–92. doi: 10.1073/pnas.81.4.1189
   PubMed Web of Science ®Google Scholar
• Banks GB, Combs AC, Odom GL, Bloch RJ, Chamberlain JS. Muscle structure influences utrophin expression in mdx mice. PLoS Genet 2014;10:e1004431. doi: 10.1371/journal.pgen.1004431
   PubMed Web of Science ®Google Scholar
• Collins CA, Morgan JE. Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies. Int J Exp Pathol 2003;84:165–72. doi: 10.1046/j.1365-2613.2003.00354.x
   PubMed Web of Science ®Google Scholar
• Rodriguez MC, Tarnopolsky MA. Patients with dystrophinopathy show evidence of increased oxidative stress. Free Radic Biol Med 2003;34:1217–20. doi: 10.1016/S0891-5849(03)00141-2
   PubMed Web of Science ®Google Scholar
• Rando TA, Disatnik MH, Yu Y, Franco A. Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord 1998;8:14–21. doi: 10.1016/S0960-8966(97)00124-7
   PubMed Web of Science ®Google Scholar
• Messina S, Altavilla D, Aguennouz M, Seminara P, Minutoli L, Monici MC, et al. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am J Pathol 2006;168:918–26. doi: 10.2353/ajpath.2006.050673
   PubMed Web of Science ®Google Scholar
• Barnes JL, Gorin Y. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int 2011;79:944–56. doi: 10.1038/ki.2010.516
   PubMed Web of Science ®Google Scholar
• Williams IA, Allen DG. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 2007;293:H1969–77. doi: 10.1152/ajpheart.00489.2007
   PubMed Web of Science ®Google Scholar
• Whitehead NP, Pham C, Gervasio OL, Allen DG. N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 2008;586:2003–14. doi: 10.1113/jphysiol.2007.148338
   PubMed Web of Science ®Google Scholar
• Pan Y, Chen C, Shen Y, Zhu CH, Wang G, Wang XC, et al. Curcumin alleviates dystrophic muscle pathology in mdx mice. Mol Cells 2008;25:531–7.
   PubMed Web of Science ®Google Scholar
• Hori YS, Kuno A, Hosoda R, Tanno M, Miura T, Shimamoto K, et al. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. J Pharmacol Exp Ther 2011;338:784–94. doi: 10.1124/jpet.111.183210
   PubMed Web of Science ®Google Scholar
• Nakae Y, Dorchies OM, Stoward PJ, Zimmermann BF, Ritter C, Ruegg UT. Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea. Histochem Cell Biol 2012;137:811–27. doi: 10.1007/s00418-012-0926-3
   PubMed Web of Science ®Google Scholar
• Dorchies OM, Wagner S, Vuadens O, Waldhauser K, Buetler TM, Kucera P, et al. Green tea extract and its major polyphenol (−)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am J Physiol Cell Physiol 2006;290:C616–25. doi: 10.1152/ajpcell.00425.2005
   PubMed Web of Science ®Google Scholar
• Sun C, Yang C, Xue R, Li S, Zhang T, Pan L, et al. Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2. J Appl Physiol (1985) 2015;118:224–37. doi: 10.1152/japplphysiol.00744.2014
   PubMed Web of Science ®Google Scholar
• Sun CC, Li SJ, Yang CL, Xue RL, Xi YY, Wang L, et al. Sulforaphane attenuates muscle inflammation in dystrophin-deficient mdx mice via NF-E2-related factor 2 (Nrf2)-mediated Inhibition of NF-kappaB signaling pathway. J Biol Chem 2015;290:17784–95. doi: 10.1074/jbc.M115.655019
   PubMed Web of Science ®Google Scholar
• Ohno K, Ito M, Ichihara M, Ito M. Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxid Med Cell Longev 2012;2012:353152. doi: 10.1155/2012/353152
   PubMed Web of Science ®Google Scholar
• Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacol Ther 2014;144:1–11. doi: 10.1016/j.pharmthera.2014.04.006
   PubMed Web of Science ®Google Scholar
• Seo T, Kurokawa R, Sato B. A convenient method for determining the concentration of hydrogen in water: use of methylene blue with colloidal platinum. Med Gas Res 2012;2:1. doi: 10.1186/2045-9912-2-1
   PubMedGoogle Scholar
• Johnson RF, Johnson AK. Light–dark cycle modulates drinking to homeostatic challenges. Am J Physiol 1990;259:R1035–42.
   Google Scholar
• Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315–424. doi: 10.1152/physrev.00029.2006
   PubMed Web of Science ®Google Scholar
• Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 2009;18:482–96. doi: 10.1093/hmg/ddn376
   PubMed Web of Science ®Google Scholar
• Keeling RM, Golumbek PT, Streif EM, Connolly AM. Weekly oral prednisolone improves survival and strength in male mdx mice. Muscle Nerve 2007;35:43–8. doi: 10.1002/mus.20646
   PubMed Web of Science ®Google Scholar
• Lim JH, Kim DY, Bang MS. Effects of exercise and steroid on skeletal muscle apoptosis in the mdx mouse. Muscle Nerve 2004;30:456–62. doi: 10.1002/mus.20139
   PubMed Web of Science ®Google Scholar
• Dogra C, Changotra H, Wergedal JE, Kumar A. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch. J Cell Physiol 2006;208:575–85. doi: 10.1002/jcp.20696
   PubMed Web of Science ®Google Scholar
• Hnia K, Hugon G, Rivier F, Masmoudi A, Mercier J, Mornet D. Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice. Am J Pathol 2007;170:633–43. doi: 10.2353/ajpath.2007.060344
   PubMed Web of Science ®Google Scholar
• Messina S, Bitto A, Vita GL, Aguennouz M, Irrera N, Licata N, et al. Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice. Biofactors 2015;41:324–9.
   PubMed Web of Science ®Google Scholar
• Dominov JA, Kravetz AJ, Ardelt M, Kostek CA, Beermann ML, Miller JB. Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice. Hum Mol Genet 2005;14:1029–40. doi: 10.1093/hmg/ddi095
   PubMed Web of Science ®Google Scholar
• Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007;13:688–94. doi: 10.1038/nm1577
   PubMed Web of Science ®Google Scholar
• Itoh T, Fujita Y, Ito M, Masuda A, Ohno K, Ichihara M, et al. Molecular hydrogen suppresses FcepsilonRI-mediated signal transduction and prevents degranulation of mast cells. Biochem Biophys Res Commun 2009;389:651–6. doi: 10.1016/j.bbrc.2009.09.047
   PubMed Web of Science ®Google Scholar
• Itoh T, Hamada N, Terazawa R, Ito M, Ohno K, Ichihara M, et al. Molecular hydrogen inhibits lipopolysaccharide/interferon gamma-induced nitric oxide production through modulation of signal transduction in macrophages. Biochem Biophys Res Commun 2011;411:143–9. doi: 10.1016/j.bbrc.2011.06.116
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Yamafuji M, Tachibana T, Nakabeppu Y, Noda M, Nakaya H. Oral ‘hydrogen water’ induces neuroprotective ghrelin secretion in mice. Sci Rep 2013;3:3273. doi: 10.1038/srep03273
   PubMed Web of Science ®Google Scholar
• Ito M, Hirayama M, Yamai K, Goto S, Ichihara M, Ohno K. Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson's disease in rats. Med Gas Res 2012;2:15. doi: 10.1186/2045-9912-2-15
   PubMedGoogle Scholar
• Ichihara M, Sobue S, Ito M, Ito M, Hirayama M, Ohno K. Beneficial biological effects and the underlying mechanisms of molecular hydrogen – comprehensive review of 321 original articles. Med Gas Res 2015;5:12. doi: 10.1186/s13618-015-0035-1
   PubMed Web of Science ®Google Scholar
• Yoritaka A, Takanashi M, Hirayama M, Nakahara T, Ohta S, Hattori N. Pilot study of H(2) therapy in Parkinson's disease: a randomized double-blind placebo-controlled trial. Mov Disord 2013;28:836–9. doi: 10.1002/mds.25375
   PubMed Web of Science ®Google Scholar
• Ostojic SM, Stojanovic MD. Hydrogen-rich water affected blood alkalinity in physically active men. Res Sports Med 2014;22:49–60. doi: 10.1080/15438627.2013.852092
   PubMed Web of Science ®Google Scholar
• Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, et al. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res 2008;28:137–43. doi: 10.1016/j.nutres.2008.01.008
   PubMed Web of Science ®Google Scholar
• Ito M, Ibi T, Sahashi K, Ichihara M, Ito M, Ohno K. Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies. Med Gas Res 2011;1:24. doi: 10.1186/2045-9912-1-24
   PubMedGoogle Scholar
• Ishibashi T, Sato B, Shibata S, Sakai T, Hara Y, Naritomi Y, et al. Therapeutic efficacy of infused molecular hydrogen in saline on rheumatoid arthritis: a randomized, double-blind, placebo-controlled pilot study. Int Immunopharmacol 2014;21:468–73. doi: 10.1016/j.intimp.2014.06.001
   PubMed Web of Science ®Google Scholar
• Aoki K, Nakao A, Adachi T, Matsui Y, Miyakawa S. Pilot study: effects of drinking hydrogen-rich water on muscle fatigue caused by acute exercise in elite athletes. Med Gas Res 2012;2:12. doi: 10.1186/2045-9912-2-12
   PubMedGoogle Scholar
• Fu Y, Ito M, Fujita Y, Ito M, Ichihara M, Masuda A, et al. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neurosci Lett 2009;453:81–5. doi: 10.1016/j.neulet.2009.02.016
   PubMed Web of Science ®Google Scholar
• Fujita K, Seike T, Yutsudo N, Ohno M, Yamada H, Yamaguchi H, et al. Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. PLoS ONE 2009;4:e7247. doi: 10.1371/journal.pone.0007247
   PubMed Web of Science ®Google Scholar
• Nakayama M, Kabayama S, Nakano H, Zhu WJ, Terawaki H, Nakayama K, et al. Biological effects of electrolyzed water in hemodialysis. Nephron Clin Pract 2009;112:C9–C15. doi: 10.1159/000210569
   Google Scholar
• Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N. Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr 2010;46:140–9. doi: 10.3164/jcbn.09-100
   PubMed Web of Science ®Google Scholar
• Kamimura N, Nishimaki K, Ohsawa I, Ohta S. Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice. Obesity (Silver Spring) 2011;19:1396–403. doi: 10.1038/oby.2011.6
   PubMed Web of Science ®Google Scholar
• Rothwell NJ, Stock MJ. Modification of body composition by clenbuterol in normal and dystrophic (mdx) mice. Biosci Rep 1985;5:755–60. doi: 10.1007/BF01119873
   PubMed Web of Science ®Google Scholar
• Anderson JE, Ovalle WK, Bressler BH. Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse. Anat Rec 1987;219:243–57. doi: 10.1002/ar.1092190305
   PubMedGoogle Scholar